Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Orexigen: Contrave Scripts Slow Down - Competition Lowers Price

Contrave from Orexigen (NASDAQ:OREX) saw a modest sales week with scripts coming in at a bit over 7,700, according to industry tracker IMS Health. This represents the first time since launch that Contrave has seen modesty in sales numbers that were not anticipated due to major holidays. It is also the first time that a competitor saw a better percentage gain than Contrave. Simply stated, there is a dynamic shift that has…